These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6773135)

  • 1. [Specific treatment of Chagas' disease].
    Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1980 Feb; 35(1):27-34. PubMed ID: 6773135
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of irradiated Trypanosoma cruzi on the pathogenesis of Chagas' disease in dogs.
    Tomlinson MJ; Chapman WL; Hanson WL; Goven AJ
    Rev Inst Med Trop Sao Paulo; 1980; 22(5):219-30. PubMed ID: 6782642
    [No Abstract]   [Full Text] [Related]  

  • 3. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic DNA vaccine against Trypanosoma cruzi infection in dogs.
    Quijano-Hernandez IA; Bolio-González ME; Rodríguez-Buenfil JC; Ramirez-Sierra MJ; Dumonteil E
    Ann N Y Acad Sci; 2008 Dec; 1149():343-6. PubMed ID: 19120245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
    Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
    Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of neural cell adhesion molecule in Chagas' myocarditis.
    Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB
    Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on infectivity and surface carbohydrates of several strains of Trypanosoma cruzi.
    González Cappa SM; Katzin AM; Añasco N; Lajmanovich S
    Medicina (B Aires); 1981; 41(5):549-55. PubMed ID: 6808285
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative changes in serum proteins in mice infected with Trypanosoma cruzi. I. Y and Nicaragua strains].
    Salata E; Rangel Hde A
    Rev Inst Med Trop Sao Paulo; 1980; 22(5):231-41. PubMed ID: 6782643
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of holothurin to significantly affect Chagas' disease in mice.
    Shoemaker JP; Hoffman RV
    J Parasitol; 1973 Oct; 59(5):929-30. PubMed ID: 4200703
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological properties of Trypanosoma cruzi metacyclic trypomastigotes: usefulness for studying Chagas' disease (brief report).
    Contreras VT; Araque WH; Delgado VS
    Biol Res; 1993; 26(1-2):315-6. PubMed ID: 7670544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of nitrofurazone (5-nitro-2-furaldehyde-semicarbazone) on the intracellular forms of Trypanosoma intracellular forms of Trypanosoma cruzi in experimental Chagas' disease].
    Andrade ZA; Brener Z
    Rev Inst Med Trop Sao Paulo; 1969; 11(3):222-8. PubMed ID: 4980992
    [No Abstract]   [Full Text] [Related]  

  • 14. I. The avirulence of the cultivated Y strain of Trypanosoma cruzi.
    Menezes H
    Rev Inst Med Trop Sao Paulo; 1970; 12(1):64-8. PubMed ID: 4999679
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chagas' disease and its significance for Central and South America (author's transl)].
    Berning H
    MMW Munch Med Wochenschr; 1981 Jan; 123(1):23-6. PubMed ID: 6780884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement system and the inflammatory response in experimental Chagas' disease.
    Irulegui I; Yamashiro EH; Castilho EA; de Brito T
    Rev Inst Med Trop Sao Paulo; 1982; 24(6):349-52. PubMed ID: 6820705
    [No Abstract]   [Full Text] [Related]  

  • 17. [International conference on tropical medicine "Medicine and health in the Tropics" September 11 to 15 2005. Chagas disease: renewed interest].
    Prat N; Gallineau C; Fourcade L
    Med Trop (Mars); 2005 Nov; 65(5):417-9. PubMed ID: 16465796
    [No Abstract]   [Full Text] [Related]  

  • 18. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.
    Zhang L; Tarleton RL
    J Infect Dis; 1999 Aug; 180(2):480-6. PubMed ID: 10395865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease.
    Boiani L; Davies C; Arredondo C; Porcal W; Merlino A; Gerpe A; Boiani M; Pacheco JP; Basombrío MA; Cerecetto H; González M
    Eur J Med Chem; 2008 Oct; 43(10):2229-37. PubMed ID: 18255195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chagas' disease reactivation with skin symptoms in a patient with kidney transplant.
    Gallerano V; Consigli J; Pereyra S; Gómez Zanni S; Danielo C; Gallerano RH; Guidi A
    Int J Dermatol; 2007 Jun; 46(6):607-10. PubMed ID: 17550560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.